Moelis & Company (MC) Q3 2024 earnings summary

Executive summary

• Adjusted revenues for Q3 2024 were $281 million, with year-to-date adjusted revenues reaching $763 million, up 18% year-over-year, driven by growth across all major product areas and strong M&A activity.

• Net income for the nine months was $51.6 million, reversing a net loss of $21.1 million in the prior year period.

• The firm operates a capital-light, high free cash flow model with no debt, serving clients in over 45 countries and emphasizing organic growth and strategic hiring.

• Gradual improvement in the M&A market observed, with pipelines and announced transactions at all-time highs, though deal completion times remain extended.

• Strong demand continues for structured capital solutions and capital structure advisory, with a prolonged restructuring cycle anticipated due to upcoming non-investment grade debt maturities.

Financial highlights

• Q3 2024 adjusted revenues were $281 million; first nine months: $763 million, up 18% year-over-year.

• Q3 2024 net income was $19.2 million, compared to a net loss of $11.4 million in Q3 2023.

• Adjusted Q3 2024 operating income margin was 8.1%, with compensation ratio at 75% and non-compensation ratio at 16.9%.

• Cash and liquid investments totaled $297.7 million at quarter-end, with no debt.

• Regular quarterly dividend of $0.60 per share declared.

Outlook and guidance

• Expectation for continued gradual improvement in business activity, with potential for acceleration depending on market and macroeconomic factors.

• A prolonged restructuring cycle is anticipated due to significant non-investment grade debt maturities.

• Commitment to organic growth, high pre-tax margins through cycles, and continued investment in talent and sector coverage.

• Compensation ratio may improve if market conditions strengthen in Q4; leverage model remains valid barring significant hiring.

• 2025 anticipated to be a good to very good year, contingent on capital raising conditions in the private equity market.